Fmoc-Glu(ODmab)-OH is an Fmoc-protected glutamic acid derivative in which the side-chain carboxyl group is modified as an ODmab (O-derivative) functionality, maintaining the amino acid backbone for peptide coupling chemistry. The molecule contains an N-terminal fluorenylmethoxycarbonyl (Fmoc) protecting group on the α-amino group and a free α-carboxylic acid (-COOH), while the side-chain terminus bears the ODmab-protected carboxyl functionality that controls chemoselectivity during stepwise assembly. In peptide synthesis workflows, this protected amino acid is used as a building block to introduce a glutamate residue bearing a side-chain carboxyl protected in the ODmab form, supporting synthesis and subsequent downstream functionalization or deprotection depending on the experimental design.
CAT No: CP26924
CAS No:268730-86-5
Synonyms/Alias:Fmoc-Glu(ODmab)-OH;268730-86-5;(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-5-((4-((1-(4,4-dimethyl-2,6-dioxocyclohexylidene)-3-methylbutyl)amino)benzyl)oxy)-5-oxopentanoicacid;MolPort-020-004-160;CF-797;ZINC150339216;AK-49632;FT-0696175;Fmoc-Glu(ODmab)-OH;(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-5-[[4-[[1-(2-hydroxy-4,4-dimethyl-6-oxocyclohexen-1-yl)-3-methylbutylidene]amino]phenyl]methoxy]-5-oxopentanoic acid;L-Glutamic acid, N-[(9H-fluoren-9-ylmethoxy)carbonyl]-, 5-[[4-[[1-(4,4-dimethyl-2,6-dioxocyclohexylidene)-3-methylbutyl]amino]phenyl]methyl]ester;Fmoc-L-Glu(ODmab)-OH;MFCD00797873;(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-5-((4-((1-(4,4-dimethyl-2,6-dioxocyclohexylidene)-3-methylbutyl)amino)benzyl)oxy)-5-oxopentanoic acid;DTXSID80718515;AKOS016843527;HY-W141946;AS-30723;CS-0201736;S-268730-86-5;(2S)-5-[(4-{[1-(4,4-Dimethyl-2,6-dioxocyclohexylidene)-3-methylbutyl]amino}phenyl)methoxy]-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-5-oxopentanoic acid;(2S)-5-[(4-{[1-(4,4-DIMETHYL-2,6-DIOXOCYCLOHEXYLIDENE)-3-METHYLBUTYL]AMINO}PHENYL)METHOXY]-2-{[(9H-FLUOREN-9-YLMETHOXY)CARBONYL]AMINO}-5-OXOPENTANOIC ACID;Fmoc-L-glutamic acid-alpha-4-[N-{1-(4,4-dimethyl-2,6-dioxocyclohexylidene)-3-methylbutyl}amino] benzyl ester;Fmoc-L-glutamic acid-gamma-4-[N-{1-(4,4-dimethyl-2,6-dioxocyclohexylidene)-3-methylbutyl}amino] benzyl ester
Fmoc-Glu(ODmab)-OH is an Fmoc-protected glutamic acid derivative bearing an ODmab-protected side-chain carboxyl group, providing a chiral amino acid building block with orthogonally protected functionality. The molecule contains an Fmoc carbamate on the α-amino group, a free α-carboxylic acid for peptide coupling, and a side-chain carboxyl masked as an ODmab acetal/ester-type protecting group that modulates reactivity during synthesis. The protected side-chain reduces undesired side reactions such as intramolecular cyclization or premature activation, while the stereodefined glutamate backbone supports controlled incorporation into peptide sequences. The combination of an acid-bearing α-position and a protected γ-carboxyl enables downstream deprotection and functional group unveiling for further derivatization, fragment elaboration, or biochemical labeling workflows.
1. Peptide Synthesis
Fmoc-Glu(ODmab)-OH is used in solid-phase and solution-phase peptide synthesis where glutamate residues require orthogonal protection to manage side-chain chemistry. The Fmoc group enables standard base-labile deprotection to reveal the α-amino functionality for sequential coupling, while the free α-carboxylic acid supports amide bond formation with activated carboxyl partners. The ODmab-protected γ-carboxyl suppresses side-chain participation during chain assembly, reducing risks of side reactions that can complicate purification and sequence fidelity. After peptide assembly, ODmab deprotection can generate a glutamate side-chain handle suitable for further conjugation, charge-state tuning, or conversion into additional functional motifs.
2. Side-Chain Functionalization
Fmoc-Glu(ODmab)-OH is applied to amino acid derivatization strategies that require selective unveiling of the glutamate side-chain carboxyl group after peptide or intermediate construction. The ODmab protection pattern provides a controlled point of reactivity at the γ-carboxyl, allowing subsequent transformations such as activation for amide/ester formation, salt formation for physicochemical tuning, or conversion into side-chain analogs used in peptidomimetic design. The stereodefined glutamate backbone preserves spatial arrangement important for molecular recognition studies and for maintaining consistent charge distribution across analog series. Downstream functionalized products derived from the deprotected side-chain can serve as intermediates for chemical biology probes, linker-bearing peptides, or scaffold diversification in synthetic organic chemistry.
3. Chemical Biology Probes
Fmoc-Glu(ODmab)-OH is suitable for chemical biology workflows that require incorporation of a glutamate residue with protected side-chain chemistry for later conjugation. The protected γ-carboxyl can be carried through peptide building steps while maintaining compatibility with common peptide coupling conditions, enabling late-stage introduction of functional groups such as linkers, affinity tags, or labeling handles. The Fmoc-protected α-amino group supports assembly of defined peptide segments used for target engagement studies, receptor-binding mimics, or enzyme-assay substrates where glutamate positioning influences binding and catalytic recognition. Deprotection of the ODmab group provides a reactive carboxyl site for coupling to electrophiles or for preparing derivatives used in biochemical research intermediate preparation.
4. Peptidomimetics And SAR Studies
Fmoc-Glu(ODmab)-OH is employed in peptidomimetic construction and structure-activity relationship studies where controlled glutamate side-chain presentation is required across analog libraries. The orthogonal protection strategy allows systematic variation of the γ-carboxyl-derived functionality without perturbing the peptide backbone during synthesis, supporting parallel synthesis of analogs with altered charge, polarity, or linker architecture. The defined stereochemistry at the glutamate α-center helps maintain conformational and electrostatic features that often govern biomolecular interactions in SAR campaigns. Manufactured as a protected amino acid building block, the compound can be converted into a family of side-chain-modified intermediates that feed into medicinal chemistry and biochemical assay development pipelines.
5. Pharmaceutical Manufacturing Intermediates
Fmoc-Glu(ODmab)-OH is applicable to pharmaceutical manufacturing and process chemistry contexts where protected amino acid intermediates are needed for scalable peptide intermediate preparation. The Fmoc carbamate provides a robust protecting-group handle for α-amino functionality during controlled coupling steps, while the ODmab-protected side-chain carboxyl can be managed as an orthogonally protected group to limit side reactions during manufacturing-scale synthesis. The presence of a free α-carboxylic acid supports predictable peptide coupling chemistry, enabling integration into defined synthetic routes for peptide-based active ingredients or peptide intermediates. Deprotection and downstream conversion of the glutamate side-chain can be aligned with manufacturing process design to generate specific functional forms required for subsequent formulation-relevant transformations and final intermediate generation.
1. Cationic cell-penetrating peptides are potent furin inhibitors
4. Store-operated Ca2+ entry sustains the fertilization Ca2+ signal in pig eggs
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.